In This Article:
-
The U.S. government is preparing to launch vaccines for children below five in conjunction with educational and outreach efforts, pending approval by federal regulators, the Wall Street Journal reports.
-
The government looks to provide ten million initial doses as the virus spreads nationwide, leaving the parents anxious.
-
The vaccinations could begin by June 21, subject to the regulatory approval for Moderna, Inc (NASDAQ: MRNA), Pfizer, Inc (NYSE: PFE), and partner BioNTech SE (NASDAQ: BNTX).
-
Equal amounts of vaccines from Pfizer and Moderna will be available on approval.
-
Five million doses have been made available for preorders by states, community health centers, and pharmacies. Another five million doses will be made available for preorder.
-
The government aimed to make them available through public-health clinics, community health centers, pharmacies including children’s hospitals, health systems, and pop-up clinics at children’s museums.
-
Vaccination rates for children between 5 and 18 years trailed those for older people.
-
An FDA advisory committee will meet on June 14-15 to review the vaccination data, followed by a CDC review on June 17-18.
-
Price Action: MRNA shares traded higher by 1.25% at $150.38 in the premarket on the last check Thursday.
-
Image by x3 from Pixabay
See more from Benzinga
-
Pfizer Seeks FDA Approval For Three Covid Vaccine Doses For Children Below Five
-
GSK To Scoop Clinical Stage US Biotech Affinivax For $3.3B To Shore Up Vaccine Business
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.